However, our group has reported that low EVI1 expression was an independent adverse prognostic factor for relapse-free survival (RFS) and overall survival (OS) in pediatric B-ALL patients (18). The gene discussed is MECOM; the disease is precursor B-cell acute lymphoblastic leukemia.